LEADERSHIP

Led with experience, backed by an eye for innovation

Separator

Inscripta® is led by an experienced management team and board who have been behind some of the most innovative life science and genomic technology companies in the world. The company is backed by a world class group of institutional investors and leading venture capital firms in the industry.

Separator

Inscripta Team

Sri Kosaraju
President and Chief Executive Officer 
Ron McGrath
Chief Financial Officer
Justin Ferber
General Counsel
Tom Rosso
Vice President, Operations and Product Development
Elizabeth Holland
Vice President, Human Resources
Nandini Krishnamurthy
Vice President, Microbial Business Area
Deanna Church
Vice President, Mammalian Business Area and Software Strategy

Inscripta Board

John Stuelpnagel
Chairman
Kristala Prather
Board of Directors
Bryan Roberts
Board of Directors
Roger Wyse
Board of Directors
Sri Kosaraju
Board of Directors